PYC Therapeutics (ASX: PYC) Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

PYC Therapeutics is a clinical-stage biotechnology company focused on developing RNA-based therapies for genetic diseases. It integrates RNA drug design with a delivery approach that uses a library of naturally derived peptides to help the therapeutic reach target cells.

Discovery and laboratory work take place in Australia, while preclinical and clinical activities are centered in San Francisco, California. In April 2026, the company announced progress on PYC-001, its candidate for Autosomal Dominant Optic Atrophy.

Sign up for free to view info

Company overview Employee directory